The Effectiveness of Motivational Interviewing (MINT) and Text Message Reminders on Medication Adherence among Patients with Heart Disease.

Not Applicable

• Conditions: Medication Adherence; Medication Non-adherence; Cardiac Disease; Heart Disease; Cardiovascular - Coronary heart disease

• Registration Number: ACTRN12616000910404
• Lead Sponsor: Ali Hussein Alek Al-Ganmi

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-07-08
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 28

Inclusion Criteria

1)18 years of age or older;
2) Established diagnosis of cardiac disease by their physician and referred to the cardiac rehabilitation program at POWH;
3) Prescribed at least one cardio-protective medication at least 7 days prior to recruitment;
4)They must have primary responsibility for taking their medications themselves (i.e. whilst a carer may play a role in supporting or prompting medication taking, they should not be identified as being accountable for ensuring the patient’s adherence to their medication schedule);
5)Participants must be able to speak, read and understand English, own a personal mobile phone, and be able to receive and reply to phone calls and text messages;
6)They must be willing to give written or oral informed consent to participate to in the study.
7)To be eligible for the trial phase, patients must be identified with at least one medication non-adherence factor, indicated by results of the medication adherence questionnaire and responses to the interview questions.

Exclusion Criteria

Patients who are deaf, blind or unable to accept phone calls will be excluded. Those clinically judged with cognitive impairment that limits their ability to understand and answer study questions will be excluded.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Self-reported medication adherence/non-adherence rate. This outcome will be assessed by the Medication Adherence Questionnaire (MAQ). [Timepoint: at baseline. ];Medication Adherence Factors. These will be measured by: 1) Adherence to Refills and Medications Scale, 2) Belief about Medicine Questionnaire, 3) Medication Adherence Self-Efficacy Scale-Revised, and 4) Medication Specific Social Support.[Timepoint: at baseline.]

Secondary Outcome Measures

Name	Time	Method
Self-reported medication adherence/non-adherence rate. This outcome will be assessed by the Medication Adherence Questionnaire (MAQ). [Timepoint: at 6 months post-intervention commencement. ];Medication Adherence Factors. These will be measured by: 1) Adherence to Refills and Medications Scale, 2) Belief about Medicine Questionnaire, 3) Medication Adherence Self-Efficacy Scale-Revised, and 4) Medication Specific Social Support. [Timepoint: at 6 months post-intervention commencement. ]